ClinicalTrials.govpublic full text
Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS
pdac - pancreatic ductal adenocarcinoma, colorectal cancer, expanded access
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1009751
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.